Theriva Biologics, Inc. (TOVX) is a publicly traded Healthcare sector company. As of May 21, 2026, TOVX trades at $0.30 with a market cap of $13.54M and a P/E ratio of -0.14. TOVX moved +11.05% today. Year to date, TOVX is +24.48%; over the trailing twelve months it is -31.22%. Its 52-week range spans $0.16 to $2.64. Analyst consensus is buy with an average price target of $2.50. Rallies surfaces TOVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Theriva Biologics, Inc. (TOVX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TOVX moved +11.05% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.30 |
| Market Cap | $13.54M |
| P/E Ratio | -0.14 |
| EPS | $-2.08 |
| Dividend Yield | 0.05% |
| 52-Week High | $2.64 |
| 52-Week Low | $0.16 |
| Volume | 158.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-23.74M |
| Gross Margin | 0.00% |
2 analysts cover TOVX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.50.